Aguilar, Jia D.
HRN: 26-48-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2025
CEFUROXIME 500MG (TAB)
01/06/2025
01/12/2025
PO
500 Mg Tab
BID
Sp Nsvd With Rmle
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes